BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 37165697)

  • 1. Hereditary colorectal, gastric, and pancreatic cancer: comprehensive review.
    Seppälä TT; Burkhart RA; Katona BW
    BJS Open; 2023 May; 7(3):. PubMed ID: 37165697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
    Syngal S; Brand RE; Church JM; Giardiello FM; Hampel HL; Burt RW;
    Am J Gastroenterol; 2015 Feb; 110(2):223-62; quiz 263. PubMed ID: 25645574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis and diagnostics of hereditary colorectal cancers.
    Abdel-Rahman WM; Peltomäki P
    Ann Med; 2004; 36(5):379-88. PubMed ID: 15478312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary Cancer Syndromes-A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer Syndromes.
    Samadder NJ; Baffy N; Giridhar KV; Couch FJ; Riegert-Johnson D
    Mayo Clin Proc; 2019 Jun; 94(6):1099-1116. PubMed ID: 31171120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the PRED-IdF, a regional network dedicated to patients with hereditary predisposition to digestive cancers].
    Perrod G; Samaha E; Bats AS; Cellier C
    Ann Pathol; 2020 Apr; 40(2):114-119. PubMed ID: 32199653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of patients with hereditary gastrointestinal cancer syndromes.
    Moreira L; Castells A
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):923-935. PubMed ID: 27938787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary gastric and pancreatic cancer predisposition syndromes].
    Leoz ML; Sánchez A; Carballal S; Ruano L; Ocaña T; Pellisé M; Castells A; Balaguer F; Moreira L
    Gastroenterol Hepatol; 2016; 39(7):481-93. PubMed ID: 26916701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Colorectal Cancer in Hereditary Syndromes.
    Cunningham LA; Gasior A; Kalady MF
    Surg Oncol Clin N Am; 2022 Apr; 31(2):307-319. PubMed ID: 35351280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary Colorectal Cancer.
    Hampel H; Kalady MF; Pearlman R; Stanich PP
    Hematol Oncol Clin North Am; 2022 Jun; 36(3):429-447. PubMed ID: 35577708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary Polyposis Syndromes: Opportunities for Early Detection in Individuals and Families.
    Mahon SM
    Clin J Oncol Nurs; 2018 Apr; 22(2):151-156. PubMed ID: 29547604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.
    Vangala DB; Cauchin E; Balmaña J; Wyrwicz L; van Cutsem E; Güller U; Castells A; Carneiro F; Hammel P; Ducreux M; van Laethem JL; Matysiak-Budnik T; Schmiegel W
    Eur J Cancer; 2018 Nov; 104():91-103. PubMed ID: 30342310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer.
    Allen BA; Terdiman JP
    Best Pract Res Clin Gastroenterol; 2003 Apr; 17(2):237-58. PubMed ID: 12676117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary gastric cancer syndromes and their association with specific histological subtypes].
    Dardenne A; Sirmai L; Metras J; Enea D; Svrcek M; Benusiglio PR
    Bull Cancer; 2023 May; 110(5):512-520. PubMed ID: 35963792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial colorectal cancer.
    Lung MS; Trainer AH; Campbell I; Lipton L
    Intern Med J; 2015 May; 45(5):482-91. PubMed ID: 25955461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary cancer in adults.
    Lynch HT; Fusaro RM; Lynch J
    Cancer Detect Prev; 1995; 19(3):219-33. PubMed ID: 7750110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.
    Gupta S; Provenzale D; Llor X; Halverson AL; Grady W; Chung DC; Haraldsdottir S; Markowitz AJ; Slavin TP; Hampel H; ; Ness RM; Weiss JM; Ahnen DJ; Chen LM; Cooper G; Early DS; Giardiello FM; Hall MJ; Hamilton SR; Kanth P; Klapman JB; Lazenby AJ; Lynch PM; Mayer RJ; Mikkelson J; ; Peter S; Regenbogen SE; Dwyer MA; ; Ogba N
    J Natl Compr Canc Netw; 2019 Sep; 17(9):1032-1041. PubMed ID: 31487681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.
    Dunlop MG; ;
    Gut; 2002 Oct; 51 Suppl 5(Suppl 5):V21-7. PubMed ID: 12221036
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical management of hereditary colorectal cancer syndromes.
    Vasen HF; Tomlinson I; Castells A
    Nat Rev Gastroenterol Hepatol; 2015 Feb; 12(2):88-97. PubMed ID: 25582351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.